SB 4070 amends the Social Security Act in two linked ways: it explicitly recognizes Doctors of Podiatric Medicine (DPMs) in Medicaid’s physician coverage rules, and it revises Medicare’s statutory language for therapeutic diabetic shoes to specify who may document need and who may fit and furnish the footwear. Together the changes aim to increase access to foot-and-ankle care for people with diabetes and to clarify the documentation and supplier rules that govern Medicare coverage for therapeutic shoes.
These are targeted, technical edits rather than a wholesale benefits expansion. The Medicaid change alters statutory references so state Medicaid programs must cover physician services furnished by podiatrists; the Medicare change prescribes particular clinical findings and attestation language and delegates to HHS the authority to define qualified fitters.
Both edits create compliance, billing, and administrative consequences for providers, Medicaid programs, Medicare contractors, and DME suppliers that stakeholders will need to operationalize.
At a Glance
What It Does
The bill amends section 1905(a)(5)(A) to include paragraph (3) of 1861(r), bringing podiatric physicians within Medicaid’s statutory definition of physician services, and replaces the text of 1861(s)(12) to set specific documentation, attestation, and supplier rules for extra‑depth or custom-molded diabetic shoes with inserts. It also inserts those footwear items into the physician self‑referral (Stark) statute as a category.
Who It Affects
Directly affected parties include state Medicaid programs and their managed care contractors, Doctors of Podiatric Medicine and their billing offices, Medicare Part B beneficiaries with diabetes who use therapeutic footwear, and suppliers such as pedorthists and orthotists who may be designated as qualified fitters and furnishers by the Secretary.
Why It Matters
The Medicaid change removes an interpretive barrier that has limited podiatric physicians’ ability to bill Medicaid as ‘physicians,’ potentially increasing access to covered foot care. The Medicare edits standardize the clinical documentation and narrow who may furnish and fit therapeutic shoes, affecting claim acceptance, supplier enrollment, and provider workflows as agencies translate statutory attestation language into operational rules.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill does two discrete but related things. First, it fixes a statutory reference in the Medicaid physician‑services provision (section 1905(a)(5)(A)) to expressly encompass podiatric physicians by adding paragraph (3) of section 1861(r) to the citation.
Practically, that change means services delivered by Doctors of Podiatric Medicine will be treated as physician services under Medicaid—which affects provider enrollment, allowable billing codes, and state plan interpretations. The change takes effect January 1, 2026, but the statute gives states extra time if they need to change state law to conform their Medicaid plans.
Second, the bill rewrites the Medicare item description for therapeutic footwear (section 1861(s)(12)). It requires that a ‘‘physician as defined in subsection (r)’’ document specific clinical indicators—peripheral neuropathy with altered sensation or motor control, history of pre‑ulcerative lesions or foot ulceration, foot deformity, prior lower extremity amputation, or poor circulation—and attest that the patient has diabetes, is under a comprehensive diabetes‑related plan of care, and needs the footwear.
It further requires that the shoes be fitted and furnished by a physician or a ‘‘qualified individual’’ (for example, a pedorthist or orthotist) as defined by the Secretary. This provision becomes effective January 1, 2028, and the bill also amends the physician self‑referral statute to add therapeutic shoes as a listed item for the statute’s purposes.Implementation will depend on HHS rulemaking and operational guidance.
The Secretary must identify who counts as a qualified fitter/furnisher and how attestations translate into claims documentation. State Medicaid agencies will need to update provider manuals and claims edits; Medicare Administrative Contractors will revise medical necessity screens and supplier enrollment categories.
The statutory attestation language tightens what clinical findings a physician must note, which could reduce informal approvals but also expose providers to documentation challenges during audits.
The Five Things You Need to Know
The amendment to section 1905(a)(5)(A) replaces the single citation to section 1861(r)(1) with references to paragraphs (1) and (3) of 1861(r), explicitly bringing Doctors of Podiatric Medicine into Medicaid’s statutory physician definition.
The Medicaid recognition provision takes effect for services furnished on or after January 1, 2026, with a statutory safe harbor that delays enforcement for states that require state‑law changes until the end of the first calendar quarter after their next regular legislative session.
The revised Medicare provision (new text for 1861(s)(12)) requires a physician ‘as defined in subsection (r)’ to document specific clinical findings—peripheral neuropathy (with altered sensation or motor control), history of pre‑ulcerative calluses or foot ulceration, foot deformity, prior lower extremity amputation, or poor circulation—and to attest that the beneficiary has diabetes, is under a comprehensive diabetes care plan, and needs the shoes.
The bill requires that extra‑depth or custom‑molded shoes with inserts be fitted and furnished by a physician or a Secretary‑defined qualified individual (explicitly listing pedorthists and orthotists as examples), shifting some supplier authorization decisions to HHS rulemaking.
The Medicare footwear changes (including the conforming insertion into section 1877(h)(6)) apply to items and services furnished on or after January 1, 2028, creating a staggered timeline between the Medicaid and Medicare provisions.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Statutory recognition of podiatrists in Medicaid
This provision amends 1905(a)(5)(A) to substitute the existing reference to 1861(r)(1) with a reference to both paragraphs (1) and (3) of section 1861(r). The mechanical change resolves an omission that left podiatric physicians out of Medicaid’s statutory ‘physician’ definition in some interpretations. The practical effect is to make physician‑level reimbursement and related coverage rules available to DPMs under federal Medicaid law; states may still define scope and billing details within their plans.
Effective date and state plan compliance window
The bill makes the Medicaid recognition effective January 1, 2026, but includes a compliance extension for states that must pass legislation to bring their plans into alignment. The statute ties the extension to the timing of the state legislature’s next regular session and treats two‑year sessions as discrete years, which creates a predictable but potentially long compliance timeline for some states. States should expect to update provider enrollment rules, managed care contract language, and claims edits once they implement the change.
Redefined Medicare criteria for therapeutic diabetic footwear
Section 3 replaces the text of 1861(s)(12) with explicit clinical and administrative requirements: a physician defined in 1861(r) must document certain neuropathic or circulatory findings, attest to an active diabetes diagnosis and comprehensive plan of care, and state that the footwear is needed. The language focuses on specific risk factors associated with foot ulcers and amputations rather than a generic ‘need’ threshold, which gives Medicare a statutory basis to deny claims lacking those documented findings.
Who may fit and furnish footwear; Secretary’s authority
The new statutory text requires that shoes be fitted and furnished by a physician or by a ‘qualified individual’ as established by the Secretary, and names pedorthists and orthotists as examples. That delegation of definitional authority means HHS will determine supplier categories, credentialing criteria, and potentially training or certification standards. The result is a combined clinical-and-supplier framework that CMS must operationalize via guidance and contractor edits.
Conforming Stark amendment and Medicare effective date
The bill inserts the footwear category into section 1877(h)(6) (the physician self‑referral exceptions list) to align the Stark rules with the revised Medicare coverage language. The Medicare provisions apply to items and services furnished on or after January 1, 2028, giving time for HHS to issue definitions and for suppliers to adjust enrollment and compliance processes before the statutory standard applies.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicaid beneficiaries with diabetes and foot pathology — The explicit recognition of DPMs as physicians under Medicaid should improve direct access to covered podiatric services and reduce administrative denials tied to provider type.
- Doctors of Podiatric Medicine — DPMs gain a clearer statutory footing to enroll as physicians, bill physician rates where applicable, and assert parity in Medicaid provider networks, which may expand practice viability and referral patterns.
- Medicare beneficiaries at high risk for foot complications — The statutorily specified clinical criteria create a clearer, predictable pathway for therapeutic footwear coverage when physicians document the listed risk factors and a comprehensive care plan.
- Pedorthists and orthotists (potentially) — Because the bill authorizes the Secretary to designate qualified fitters, certified pedorthists and orthotists may secure a clearer role and billing pathway as recognized furnishers if HHS adopts them in rulemaking.
- State Medicaid programs concerned with preventive care — Programs focused on reducing ulceration and amputations may benefit from increased access to early podiatric intervention, which can lower long‑term acute care and hospitalization costs.
Who Bears the Cost
- State Medicaid agencies — Expanding ‘physician’ status for podiatrists may increase utilization of physician‑level services and associated payments, necessitating budget adjustments and potential state legislative action to update statutes or provider manuals.
- Medicare program (Part B) and CMS contractors — Narrowing coverage to footwear that meets documented clinical criteria and recognizing new supplier categories will require contractor edits, supplier tracking, and potentially higher short‑term expenditures for footwear claims.
- Providers and suppliers — Physicians, pedorthists, orthotists and DME suppliers must implement new documentation and attestation practices, modify templates, and prepare for claims reviews or audits under the tightened medical‑necessity standard.
- Managed care organizations — Medicaid MCOs will need to update medical policy, prior‑authorization rules, and network agreements to reflect podiatrist recognition and to avoid payment denials.
- Smaller practices and rural clinics — Administrative burdens from new attestations, credentialing, and potential HHS rule changes could disproportionately fall on smaller providers with limited compliance resources.
Key Issues
The Core Tension
The central dilemma is access versus control: the bill improves statutory access to podiatric care and sets clearer clinical gates for therapeutic footwear to prevent complications, but it simultaneously shifts important definitional and operational choices to HHS and state legislatures, risking short‑term administrative disruption, uneven implementation across states, and a possible increase in utilization and near‑term public program costs while aiming to prevent costlier complications later.
The bill trades clarity for administrative complexity. On one hand, naming DPMs in the Medicaid physician definition removes an interpretive barrier and can reduce denials that turned on provider classification.
On the other, it pushes a lot of detail—particularly for Medicare footwear coverage—into HHS rulemaking. The statute prescribes clinical findings and attestations but leaves the definition of ‘qualified individual’ and the operationalization of attestations to the Secretary; the timing lag to 2028 delays effect but also concentrates the practical reforms into future regulatory guidance.
That creates a period of uncertainty where providers may not know which supplier credentials or documentation formats CMS will accept.
There is also an implementation risk across jurisdictions. States must align their Medicaid rules and, where state law changes are required, the compliance clock depends on legislative calendars; that will produce a patchwork of effective dates and local policies.
For Medicare, inserting footwear into the physician self‑referral language reduces one legal barrier to furnishing but raises questions about how Stark and anti‑kickback protections interplay with new supplier models (for example, physician‑owned orthotic labs). Finally, the attestation‑focused approach narrows accepted clinical justification, which could reduce inappropriate claims but also increase the frequency of post‑payment reviews and beneficiary interruptions in care if documentation is judged insufficient.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.